Cell Proliferation Kit Market Trends

  • Report ID: 3860
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Cell Proliferation Kit Market Trends

Growth Drivers

  • Increasing Rate of Patients Diagnosed with Cancer, and Tumors – On account of the increasing prevalence of cancer, the market is expected to expand more in the upcoming years. According to the World Health Organization, smoking, drinking alcohol, eating poorly, not exercising, and air pollution are risk factors for cancer and other noncommunicable diseases. Approximately, 90–95% cancer cases among Americans can be attributed to lifestyle factors such as cigarette smoking, diet, alcohol, sun exposure, environmental pollutants, infections, stress, obesity, and physical inactivity.

  • Rising Conscious Towards Healthcare – The anxiety of probable pandemic outbreaks in the future has made people more aware about their health. According to the most recent estimates, more than 80% of the population in Jordan has health insurance (both private and public health insurance).

  • Growing Government Efforts to Reduce the Cost of Healthcare – Government agencies in both developed and developing nations are expanding their financial contributions to research and development projects and clinical trials addressing various medical diseases. In 2022, there were more than 400 thousand clinical trials registered worldwide.

  • Growing Usage of Toxicity Testing in the Food Industry – To assess the safety of food and food additives, food safety toxicological tests are a crucial tool.  In order to ensure food safety, the food industry has recently improved safety testing techniques that concentrate on microbiological contaminants recently. Further, putting food safety at risk can result in fatalities. Every year, food safety issues cause economic losses for nations all around the world. According to estimates, foodborne infections cost low- to middle-income nations at least $100 billion in losses each year.

Challenges

  • Lack of Highly Qualified Medical Personnel in Poor Economic Areas - According to a new joint report by the OECD, World Health Organization (WHO) and the World Bank, inadequate health services are preventing nations of all economic levels from making progress in improving their citizens' health. For instance, the number of health professionals migrating is also rising, which might make the shortfall worse, particularly in low- and lower-middle-income countries.
  • Dearth of Knowledge Regarding Cell Proliferation Kit
  • Limitations in Clinical and Research Applications

Cell Proliferation Kit Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~12%

Base Year Market Size (2022)

~ USD 500 Million

Forecast Year Market Size (2035)

~ USD 700 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

11.7%

Base Year Market Size (2024)

USD 624.4 million

Forecast Year Market Size (2037)

USD 2.63 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3860
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cell proliferation kit is evaluated at USD 746.76 million.

The cell proliferation kit market size was valued at USD 624.4 million in 2024 and is set to exceed USD 2.63 billion by 2037, expanding at over 11.7% CAGR during the forecast period i.e., between 2025-2037. Increasing rate of patients diagnosed with cancer & tumors, and the rising conscious towards healthcare will boost the market growth.

North America industry is expected to dominate majority revenue share by 2037, due to increasing frequency of new cancer cases such as melanoma, urothelial carcinoma, lung cancer, and others in the region.

The major players in the market are Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, General Electric Company, PerkinElmer Inc., F. Hoffmann-La Roche AG, Biotium, Inc., Mindray Medical International Limited, Biological Industries
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample